CIAM
AUPH icon

Caitong International Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Caitong International Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-259
Closed -$2.19K – 1947
2025
Q2 		$2.19K Buy
+259
New +$2.08K ﹤0.01% 1354

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caitong International Asset Management's AUPH Position: Q3 2025 in Review

Caitong International Asset Management sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2025, closing a stake of 259 shares — an estimated $2.19K sold.

Caitong International Asset Management first reported a position in AUPH in Q2 2025 and held it in 1 quarter. The position peaked at $2.19K in Q2 2025. 242 funds tracked by Wall St. Rank hold AUPH as of Q3 2025.

  • Caitong International Asset Management reported no remaining Aurinia Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 259 Aurinia Pharmaceuticals shares in Q3 2025, an estimated $2.19K.
  • Caitong International Asset Management first reported a position in Aurinia Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Caitong International Asset Management's Aurinia Pharmaceuticals position peaked at $2.19K in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2025.

Based on Caitong International Asset Management's 13F filing for Q3 2025, filed 19 Nov 2025.